NO20065030L - Aerosol formulation for inhalation of beta agonists. - Google Patents
Aerosol formulation for inhalation of beta agonists.Info
- Publication number
- NO20065030L NO20065030L NO20065030A NO20065030A NO20065030L NO 20065030 L NO20065030 L NO 20065030L NO 20065030 A NO20065030 A NO 20065030A NO 20065030 A NO20065030 A NO 20065030A NO 20065030 L NO20065030 L NO 20065030L
- Authority
- NO
- Norway
- Prior art keywords
- inhalation
- aerosol formulation
- beta agonists
- agonists
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Det beskrives en drivgassfri aerosolformulering som inneholder én eller flere forbindelser med den generelle formel (1), hvor restene R', R2 , R3 og X- kan ha de betydninger som er angitt i kravene og i beskrivelsen, for inhalasjon.It is disclosed a propellant-free aerosol formulation containing one or more compounds of general formula (1), wherein residues R ', R2, R3 and X- may have the meanings given in the claims and in the specification for inhalation.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004024452A DE102004024452A1 (en) | 2004-05-14 | 2004-05-14 | Aerosol formulation for the inhalation of beta agonists |
| PCT/EP2005/005028 WO2005110421A2 (en) | 2004-05-14 | 2005-05-10 | Aerosol formulation for inhalation of beta agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065030L true NO20065030L (en) | 2006-11-30 |
Family
ID=34979667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065030A NO20065030L (en) | 2004-05-14 | 2006-11-02 | Aerosol formulation for inhalation of beta agonists. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1809293B1 (en) |
| JP (1) | JP4620730B2 (en) |
| KR (1) | KR101288791B1 (en) |
| CN (1) | CN101056640A (en) |
| AR (1) | AR049096A1 (en) |
| AU (1) | AU2005244414B2 (en) |
| BR (1) | BRPI0511135B8 (en) |
| CA (1) | CA2564379C (en) |
| DE (1) | DE102004024452A1 (en) |
| DK (1) | DK1809293T3 (en) |
| EA (1) | EA012583B1 (en) |
| EC (1) | ECSP067004A (en) |
| ES (1) | ES2575925T3 (en) |
| HU (1) | HUE027780T2 (en) |
| IL (1) | IL179218A (en) |
| MX (1) | MXPA06013216A (en) |
| MY (1) | MY148403A (en) |
| NO (1) | NO20065030L (en) |
| PE (1) | PE20060311A1 (en) |
| PL (1) | PL1809293T3 (en) |
| SG (1) | SG152265A1 (en) |
| TW (1) | TWI356703B (en) |
| UA (1) | UA87312C2 (en) |
| UY (1) | UY28891A1 (en) |
| WO (1) | WO2005110421A2 (en) |
| ZA (1) | ZA200607462B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| CN101208316B (en) | 2005-08-15 | 2012-05-09 | 贝林格尔·英格海姆国际有限公司 | Method for producing betamimetics |
| CN101296700A (en) * | 2005-11-09 | 2008-10-29 | 贝林格尔·英格海姆国际有限公司 | Aerosolformulation for inhalation |
| UY30543A1 (en) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | AEROSOL FORMULATION FOR INHALATION OF BETA- AGONISTS |
| WO2010057927A1 (en) * | 2008-11-21 | 2010-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
| CA2738617A1 (en) * | 2008-11-21 | 2011-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
| EP2906218B1 (en) | 2012-10-09 | 2016-12-14 | Boehringer Ingelheim International GmbH | Beta-2-adrenoceptor agonist for the treatment of cough |
| EP3551187B1 (en) | 2016-12-12 | 2021-02-17 | Boehringer Ingelheim International GmbH | Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134590A1 (en) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | NEW BENZO HETEROCYCLES |
| US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| JPH0637388B2 (en) * | 1986-02-17 | 1994-05-18 | 千寿製薬株式会社 | Aqueous solution |
| GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| DE10253282A1 (en) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration |
| DE102004019539A1 (en) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drugs for the treatment of respiratory diseases |
| CA2559699C (en) * | 2004-04-22 | 2012-06-19 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations containing benzoxazine for treating respiratory diseases |
| DE102004024451A1 (en) * | 2004-05-14 | 2005-12-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder formulations for inhalation containing enantiomerically pure beta agonists |
| DE102004024454A1 (en) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals |
-
2004
- 2004-05-14 DE DE102004024452A patent/DE102004024452A1/en not_active Withdrawn
-
2005
- 2005-05-10 JP JP2007512068A patent/JP4620730B2/en active Active
- 2005-05-10 ES ES05747843.0T patent/ES2575925T3/en active Active
- 2005-05-10 CN CNA2005800154865A patent/CN101056640A/en active Pending
- 2005-05-10 AU AU2005244414A patent/AU2005244414B2/en active Active
- 2005-05-10 WO PCT/EP2005/005028 patent/WO2005110421A2/en active Application Filing
- 2005-05-10 BR BRPI0511135A patent/BRPI0511135B8/en active IP Right Grant
- 2005-05-10 DK DK05747843.0T patent/DK1809293T3/en active
- 2005-05-10 PL PL05747843.0T patent/PL1809293T3/en unknown
- 2005-05-10 EA EA200602017A patent/EA012583B1/en not_active IP Right Cessation
- 2005-05-10 SG SG200902777-2A patent/SG152265A1/en unknown
- 2005-05-10 KR KR1020067026225A patent/KR101288791B1/en active IP Right Grant
- 2005-05-10 UA UAA200612949A patent/UA87312C2/en unknown
- 2005-05-10 MX MXPA06013216A patent/MXPA06013216A/en active IP Right Grant
- 2005-05-10 EP EP05747843.0A patent/EP1809293B1/en active Active
- 2005-05-10 HU HUE05747843A patent/HUE027780T2/en unknown
- 2005-05-10 CA CA2564379A patent/CA2564379C/en active Active
- 2005-05-11 UY UY28891A patent/UY28891A1/en not_active Application Discontinuation
- 2005-05-12 MY MYPI20052158A patent/MY148403A/en unknown
- 2005-05-12 PE PE2005000529A patent/PE20060311A1/en not_active Application Discontinuation
- 2005-05-13 TW TW094115491A patent/TWI356703B/en not_active IP Right Cessation
- 2005-05-13 AR ARP050101959A patent/AR049096A1/en unknown
-
2006
- 2006-09-06 ZA ZA200607462A patent/ZA200607462B/en unknown
- 2006-11-02 NO NO20065030A patent/NO20065030L/en not_active Application Discontinuation
- 2006-11-13 IL IL179218A patent/IL179218A/en active IP Right Grant
- 2006-11-13 EC EC2006007004A patent/ECSP067004A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20065030L (en) | Aerosol formulation for inhalation of beta agonists. | |
| NO20025821L (en) | 2-aminocarbonyl-9H-purine | |
| NO20062491L (en) | Benzoxazine derivatives and their use | |
| NO20090410L (en) | Aerosol formulations for inhalation of beta agonists | |
| NO20050828L (en) | indole-3-sulfur derivatives | |
| TW200730178A (en) | Aerosol formulations for the inhalation of β-agonists | |
| ATE301653T1 (en) | PYRAZOLOPYRIDINES | |
| ATE296826T1 (en) | PYRAZOLO(1,5)PYRIDINE DERIVATIVES | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| ATE433447T1 (en) | PYRIMIIDINE COMPOUNDS | |
| NO20034011L (en) | Steroids as Agonists for FXR | |
| TR200302242T2 (en) | Pyrolopyrimidines as protein kinase inhibitors | |
| NO20070555L (en) | Quinazolinone derivatives as PARP inhibitors | |
| NO20065060L (en) | Pharmaceutical combinations containing benzoxazine for the treatment of respiratory disorders | |
| NO20061839L (en) | Benzimidazole derivatives, compositions containing them, their preparation, and their use | |
| ATE332301T1 (en) | ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS | |
| NO20060147L (en) | Benzimidazole derivatives, compositions containing them, their preparation and their use | |
| WO2004100865A3 (en) | New benzimidazole derivatives | |
| WO2006096444A3 (en) | Chemical compounds | |
| ATE300541T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES | |
| NO20040881L (en) | Oral antidiabetic agents. | |
| NO20072089L (en) | Benzimidazole derivatives, compositions containing them, their preparation and their use | |
| NO20055749L (en) | Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors | |
| NO20081587L (en) | Aerosol formulation for inhalation | |
| NO20022123L (en) | Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |